Receptivity to new smokeless tobacco products among test market populations

在卷烟销量下降的背景下，无烟烟草的营销和销售却在上升 在美国目前，美国四大卷烟制造商已经推出了新的无痰卷烟， 无烟烟草产品模仿瑞典鼻烟，专门针对吸烟者。 关于如何适当地处理这些新的、相对 低亚硝胺无烟烟草产品然而，这些产品的日益普及 这是一个事实，迄今为止，几乎没有关于这些产品使用情况的基于人口的数据。的 国家癌症研究所和国家药物滥用研究所发布了一项计划， 寻求研究以提高对使用潜在减少暴露的知识的公告 烟草制品，包括发展监测系统和评估可能 例如香烟和无烟产品的双重用途。本申请针对 这些目的。此时，印第安纳波利斯和达拉斯/英尺。沃思是唯一一个 主要品牌骆驼鼻烟和万宝路鼻烟都可以买到。通过高效的双框架 抽样方法，本研究将进行一项基于人口的电话调查，4540名成年人在这些 测试市场，旨在提供消费者对新鼻烟的接受程度的证据 吸烟者和非吸烟者尝试产品的比率，要么拒绝，要么拒绝。 定期使用它，以及定期使用对吸烟模式可能产生的影响。此外该 该项目将有助于完善监督措施，并将建立基准， 认识，试验和定期使用鼻烟以及对未来危害的看法 比较可以作为广告信息、营销策略和/或产品成分 变化通过包括手机补充，它将增加如何遗漏手机的知识 只有家庭可能会对鼻烟使用的估计产生偏差，并建立能力，将手机样本纳入 人口调查。最后，如果鼻烟的采用率高到足以保证继续研究， 该项目将提供一组可以长期跟踪的答复者。

In the context of declining sales of cigarettes, the marketing and sale of smokeless tobacco is on the rise in the United States. Currently four major U.S. cigarette manufacturers have introduced new spitless, smokeless tobacco products modeled on Swedish snus and targeted specifically to cigarette smokers. There is considerable controversy about the appropriate public health approach to these new, relatively low nitrosamine, smokeless tobacco products . Nevertheless the growing availability of these products is a fact, and to date there is virtually no population-based data on the use of these products. The National Cancer Institute and the National Institute of Drug Abuse have issued a Program announcement seeking research to improve knowledge about the use of potential reduced exposure tobacco products, including developing surveillance systems and assessing behavior changes that may accompany their use such as dual use of cigarettes and smokeless products. This application is directed to those purposes. At this time, Indianapolis and Dallas/Ft. Worth are the only areas where the two major brands, Camel Snus and Marlboro Snus, are both available. By means of an efficient, dual-frame sampling approach, this study will carry out a population-based telephone survey of 4540 adults in those test markets designed to provide evidence of the nature of consumer receptivity to the new snus products, the rate at which smokers and nonsmokers are trying the product and either rejecting it or adopting it for regular use, and the likely impact of regular use on smoking patterns. In addition, the project will contribute to refinement of surveillance measures and will establish benchmarks for awareness, trial and regular use of snus as well as perceptions of harmfulness against which future comparisons can be made as advertising messages, marketing strategies and/or product constituents change. By including a cell phone supplement, it will increase knowledge of how omission of cell phone only households may bias estimates of snus use, and build capacity to integrate cell phone samples into population surveys. Finally, if the rate of snus adoption is high enough to warrant continued study, this project will provide a panel of respondents who can be followed over time.